BioLife SolutionsBLFS +4.25%72 Days Inventory is 287.27 as of Mar. 2026, which is 15% above its 10-year median of 250.62. GuruFocus rates BLFS with a GF Score™ of 72/100 and a GF Value™ of $28.57 (Fairly Valued). The stock has 5 warning signs investors should review. Among 786 Medical Devices & Instruments companies, BioLife Solutions ranks worse than 77.23% on this metric.
The historical rank and industry rank for BioLife Solutions's Days Inventory or its related term are showing as below:
BLFS'
s Days Inventory Range Over the Past 10 Years
Min: 88.79 Med: 250.62 Max: 424.28
Current: 296.64
During the past 13 years, BioLife Solutions's highest Days Inventory was 424.28. The lowest was 88.79. And the median was 250.62.
BLFS's Days Inventory is ranked worse than 77.23% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 179.86
vs BLFS: 296.64
BioLife Solutions's Days Inventory
declined
from Mar. 2025 (355.86) to Mar. 2026 (287.27).
Inventory Turnover measures how fast the company turns over its inventory within a year.
BioLife Solutions's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.32.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
BioLife Solutions's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 1.15.
BioLife Solutions (NAS:BLFS) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
BioLife Solutions's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
BioLife Solutions's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
BioLife Solutions Days Inventory Related Terms
BioLife Solutions Days Inventory Historical Data
* Premium members only.
The historical data trend for BioLife Solutions's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BLFS vs KMTS, AZTA, ATRC: Days Inventory Comparison
For the Medical Instruments & Supplies subindustry, BioLife Solutions's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BioLife Solutions Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, BioLife Solutions's Days Inventory distribution charts can be found below:
* The bar in red indicates where BioLife Solutions's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioLife Solutions (BLFS) has a Days Inventory of 287.27 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on BioLife Solutions and its competitors. This is 15% above median its historical median of 250.62. Over the past decade, BioLife Solutions' Days Inventory has ranged from 88.79 to 424.28. According to the industry distribution chart, BioLife Solutions ranks #607 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 77.2%.
Is BioLife Solutions' Days Inventory too high?
BioLife Solutions' current Days Inventory of 287.27 is 15% above median its 10-year median of 250.62. Over the past 10 years, this metric has ranged from a low of 88.79 to a high of 424.28. The Medical Devices & Instruments industry median Days Inventory is 179.86. BioLife Solutions' value of 287.27 is 59.7% above this industry median. Based on the distribution chart, BioLife Solutions ranks #607 out of 786 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, BioLife Solutions has a GF Score™ of 72/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does BioLife Solutions' Days Inventory compare to KMTS and AZTA?
According to the Medical Devices & Instruments industry distribution chart, BioLife Solutions ranks #607 out of 786 companies for Days Inventory. This places BioLife Solutions in the lower half of its industry. The industry median Days Inventory is 179.86. BioLife Solutions' value of 287.27 is 59.7% above this benchmark. Historically, BioLife Solutions' own Days Inventory has ranged from 88.79 to 424.28 over the past decade. While the company's 10-year median is 250.62 vs. the industry median of 179.86, BioLife Solutions has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.86, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BioLife Solutions's current Days Inventory of 287.27 is 59.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on BioLife Solutions and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BioLife Solutions's current Days Inventory is 287.27, which is 15% above median its own 10-year median of 250.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioLife Solutions stock overvalued right now?
Based on GuruFocus' analysis, BioLife Solutions (BLFS) is currently considered Fairly Valued. The stock's GF Value™ is $28.57, compared to a current price of $28.64 — trading 0.2% above its estimated fair value. The current Days Inventory is 287.27, which is 15% above median its 10-year median of 250.62 and 59.7% above the Medical Devices & Instruments industry median of 179.86. BioLife Solutions' overall GF Score™ is 72/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For BioLife Solutions (BLFS), the current Days Inventory is 287.27 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BioLife Solutions (BLFS) Overvalued in 2026?
Based on GuruFocus' analysis, BioLife Solutions stock appears to be overvalued.
The current stock price of $28.64 is trading 0.2% above its estimated GF Value™ of $28.57.
GuruFocus considers BioLife Solutions to be Fairly Valued.
Key valuation signals for BLFS:
Days Inventory: 287.27 (15% above median its 10-year median of 250.62)
GF Value™: $28.57 vs. price of $28.64 (0.2% above fair value)
Industry Position: 59.7% above the Medical Devices & Instruments median (#607 of 786)
No single metric tells the full story. See the BLFS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.
72GF Score
Get the complete analysis for BLFS
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BLFS has been successfully added to your 
